Steven Pieper
Financieel Directeur/CFO bij XERIS BIOPHARMA HOLDINGS, INC.
Vermogen: 658 079 $ op 30-04-2024
Actieve functies van Steven Pieper
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Financieel Directeur/CFO | 01-10-2021 | - |
Loopbaan van Steven Pieper
Eerdere bekende functies van Steven Pieper
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Catheter Connections, Inc.
 Catheter Connections, Inc. Medical SpecialtiesHealth Technology Catheter Connections, Inc. develops vascular access products. Its flagship product DualCap, designed to protect patients from acquiring infections during intravenous infusion therapy. It disinfects both IV tubing end connectors and needle-free valves. The company was founded by Michael W. Howlett, James Mercer, Vicki Farrar, and Robert Hitchcock in 2008 and is headquartered in Salt Lake City, Utah. | Operationeel Directeur | 01-01-2015 | 01-01-2017 |
| Financieel Directeur/CFO | 01-01-2015 | 01-01-2017 | |
| DURATA THERAPEUTICS INC | Financieel Directeur/CFO | - | - |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Comptroller/Controller/Auditor | 28-07-2021 | - |
| Directeur/Bestuurslid | 05-10-2021 | - | |
| Financieel Directeur/CFO | 28-07-2021 | - | |
| Corporate Officer/Principal | 01-01-2017 | 28-07-2021 |
Opleiding van Steven Pieper
| DePaul University | Undergraduate Degree |
| Loyola University of Chicago | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 7 |
Operationeel
| Director of Finance/CFO | 4 |
| Comptroller/Controller/Auditor | 1 |
| Director/Board Member | 1 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Health Technology |
Catheter Connections, Inc.
Catheter Connections, Inc. Medical SpecialtiesHealth Technology Catheter Connections, Inc. develops vascular access products. Its flagship product DualCap, designed to protect patients from acquiring infections during intravenous infusion therapy. It disinfects both IV tubing end connectors and needle-free valves. The company was founded by Michael W. Howlett, James Mercer, Vicki Farrar, and Robert Hitchcock in 2008 and is headquartered in Salt Lake City, Utah. | Health Technology |
Durata Therapeutics, Inc.
 Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Durata Therapeutics, Inc. develops and commercializes novel therapeutics for infectious diseases and acute illnesses. The company was founded on November 4, 2009 and is headquartered in Chicago, IL. | Health Technology |
- Beurs
- Insiders
- Steven Pieper
- Ervaring
